Resumen

CAMACHO-SOSA, Kirenia; RAMOS-SUZARTE, Mayra  y  VIADA-GONZALEZ, Carmen Elena. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio: prognostic tool for lung cancer. Rev.Med.Electrón. [online]. 2023, vol.45, n.6, pp. 1021-1029.  Epub 31-Dic-2023. ISSN 1684-1824.

Lung cancer is the malignant neoplasm that causes higher mortality in the world. Among the prognostic factors of this entity are the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio, hematological parameters that are used to assess inflammation and the immune response in the human body. A bibliographic review was carried out with the objective of exposing the value of the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as a prognostic tool for lung cancer, taking into account the scientific evidence published to date. A total of 46 articles were studied, of which 28 were selected for the development of the research. The quality of the studies, the level of updating on the subject in question, as well as the reliability of the source was used as selection criteria. The resources available in the Infomed network were used to select the information, including PubMed, SciELO and EBSCO, Cumed, LILACS and Scopus, as well as Medline, Academic Search Premier and MedicLatina databases. The value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as a prognostic tool in non-small cell lung cancer at all stages and with different therapeutic modalities was exposed.

Palabras clave : neutrophil-lymphocyte ratio; platelet-lymphocyte ratio; inflammation; prognosis; non-small cell lung cancer.

        · resumen en Español     · texto en Español     · Español ( pdf )